Monopar Therapeutics (MNPR) Q4 2022 Earnings

23MarConfirmed
May 22
Aug 22
Nov 22
Q4 2022
-0.22
-0.21
-0.2
-0.19

Details

Expected EPS
-0.2
Actual EPS
-0.22
Surprise EPS
-0.02
Surprise Percent
+10%

Description

Monopar Therapeutics (MNPR) has reported earnings of -0.22 per share for Q4 2022.

0 Comments

Share your thoughts